Tapewire

Nasdaq · USD

TNDM

TANDEM DIABETES CARE INC

Export transactions ↓
Tapewire entity
4682
SEC CIK
0001438133
Parsed reports
672

Last 12 months

Inside the activity.

0 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202602
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 28, 2021 Filed Jun 30, 2021 17:47 UTC
Leal JamesSVP, Operations
Exercise / conversionCommon Stock 468 $9.00 $4,212.00
Disclosure

SEC source: 0001438133-21-000106 · wf-form4_162508960433428.xml · nonDerivative · entry 2

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,731

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
June 28, 2021 Filed Jun 30, 2021 17:47 UTC
Leal JamesSVP, Operations
Exercise / conversionCommon Stock 6,667 $51.50 $343,350.50
Disclosure

SEC source: 0001438133-21-000106 · wf-form4_162508960433428.xml · nonDerivative · entry 1

Leal James · CIK 0001866570 · SVP, Operations

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,263

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
June 23, 2021 Filed Jun 25, 2021 20:28 UTC OtherCommon Stock 1,892 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000104 · wf-form4_162465291006595.xml · nonDerivative · entry 2

ROEDER DOUGLAS A · CIK 0001270735 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 992,222

F1 · kind: The reported transaction was a transfer of shares from Mr. Roeder's direct holdings to Delphi Management Partners VIII, L.L.C.

F2 · ownership.nature: The Reporting Person is a managing member of Delphi Management Partners VIII, L.L.C. ("DMP"), the general partner of Delphi Ventures VIII, L.P. As a managing member of DMP, the Reporting Person shares voting and investment power over the securities held by Delphi Ventures VIII, L.P. and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Delphi Ventures VIII, L.P., except to the extent of his proportionate pecuniary interest therein.

Read SEC document
June 23, 2021 Filed Jun 25, 2021 20:28 UTC OtherCommon Stock 1,892 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000104 · wf-form4_162465291006595.xml · nonDerivative · entry 1

ROEDER DOUGLAS A · CIK 0001270735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The reported transaction was a transfer of shares from Mr. Roeder's direct holdings to Delphi Management Partners VIII, L.L.C.

Read SEC document
June 11, 2021 Filed Jun 15, 2021 20:41 UTC GiftCommon Stock 1,000 $91.51 $91,510.00
Disclosure

SEC source: 0001438133-21-000102 · wf-form4_162378963169669.xml · nonDerivative · entry 3

BLICKENSTAFF KIM D · CIK 0001238913 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 402,390

F5 · kind: The shares were given as a bona fide gift to Martin F. Perdoux.

F2 · price: The price per share reflects the average of the high and low trading prices of the Company's stock on the transaction date.

F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

Read SEC document
June 11, 2021 Filed Jun 15, 2021 20:41 UTC GiftCommon Stock 1,000 $91.51 $91,510.00
Disclosure

SEC source: 0001438133-21-000102 · wf-form4_162378963169669.xml · nonDerivative · entry 2

BLICKENSTAFF KIM D · CIK 0001238913 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 403,390

F4 · kind: The shares were given as a bona fide gift to Eileen M. Favorite.

F2 · price: The price per share reflects the average of the high and low trading prices of the Company's stock on the transaction date.

F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

Read SEC document
June 11, 2021 Filed Jun 15, 2021 20:41 UTC GiftCommon Stock 10,000 $91.51 $915,100.00
Disclosure

SEC source: 0001438133-21-000102 · wf-form4_162378963169669.xml · nonDerivative · entry 1

BLICKENSTAFF KIM D · CIK 0001238913 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 404,390

F1 · kind: The shares were given as a bona fide gift to KDB Peoria Women's Club Fund.

F2 · price: The price per share reflects the average of the high and low trading prices of the Company's stock on the transaction date.

F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

Read SEC document
June 10, 2021 Filed Jun 15, 2021 00:12 UTC
Allen DickDirector
OtherCommon Stock 1,892 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000100 · wf-form4_162371592117007.xml · nonDerivative · entry 2

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 26,892

F1 · kind: The reported transaction was a transfer of shares from Mr. Allen's direct holdings to the Allen Family Trust.

F2 · ownership.nature: The securities are held by the Allen Family Trust dated October 12, 1981.

Read SEC document
June 10, 2021 Filed Jun 15, 2021 00:12 UTC
Allen DickDirector
OtherCommon Stock 1,892 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000100 · wf-form4_162371592117007.xml · nonDerivative · entry 1

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · kind: The reported transaction was a transfer of shares from Mr. Allen's direct holdings to the Allen Family Trust.

Read SEC document
June 09, 2021 Filed Jun 10, 2021 20:59 UTC Exercise / conversionStock Option · Derivative 500 $34.00 Strike: $34.00 $17,000.00
Disclosure

SEC source: 0001438133-21-000098 · wf-form4_162335875512522.xml · derivative · entry 3

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,000

Underlying: Common Stock · 500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option shall vest in 36 equal monthly installments from January 2, 2019.

F4 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
June 09, 2021 Filed Jun 10, 2021 20:59 UTC SaleCommon Stock 500 $90.00 $45,000.00
Disclosure

SEC source: 0001438133-21-000098 · wf-form4_162335875512522.xml · nonDerivative · entry 2

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,892

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 3, 2020.

Read SEC document
June 09, 2021 Filed Jun 10, 2021 20:59 UTC Exercise / conversionCommon Stock 500 $34.00 $17,000.00
Disclosure

SEC source: 0001438133-21-000098 · wf-form4_162335875512522.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,392

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 20:56 UTC Exercise / conversionRestricted Stock Unit · Derivative 1,219 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000095 · wf-form4_162335860091572.xml · derivative · entry 2

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,440

Underlying: Common Stock · 1,219 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company.

F3 · kind: This RSU award was granted on June 8, 2020. 33% of the RSU vested on June 8, 2021 and the remaining 67% will vest annually over the next two years.

F4 · derivative.exercise_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.

F4 · derivative.expiration_date: The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 20:56 UTC Exercise / conversionCommon Stock 1,219 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000095 · wf-form4_162335860091572.xml · nonDerivative · entry 1

McGroddy-Goetz Kathleen · CIK 0001814371 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,219

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 20:57 UTC SaleCommon Stock 2,800 $89.25 $249,901.12
Disclosure

SEC source: 0001438133-21-000096 · wf-form4_162335863493704.xml · nonDerivative · entry 3

BLICKENSTAFF KIM D · CIK 0001238913 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 414,390

F1 · shares: Shares sold are from long shares held by the Kim Blickenstaff Revocable Trust, dated April 15, 2010.

F5 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $88.90 to $89.57. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 20:57 UTC SaleCommon Stock 18,077 $88.66 $1,602,658.01
Disclosure

SEC source: 0001438133-21-000096 · wf-form4_162335863493704.xml · nonDerivative · entry 2

BLICKENSTAFF KIM D · CIK 0001238913 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 417,190

F1 · shares: Shares sold are from long shares held by the Kim Blickenstaff Revocable Trust, dated April 15, 2010.

F4 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $88.00 to $88.88. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

Read SEC document
June 08, 2021 Filed Jun 10, 2021 20:57 UTC SaleCommon Stock 17,123 $87.41 $1,496,721.43
Disclosure

SEC source: 0001438133-21-000096 · wf-form4_162335863493704.xml · nonDerivative · entry 1

BLICKENSTAFF KIM D · CIK 0001238913 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnote

Disclosed balance after: 435,267

F1 · shares: Shares sold are from long shares held by the Kim Blickenstaff Revocable Trust, dated April 15, 2010.

F2 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $87.00 to $87.87. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

F3 · ownership.nature: The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.

Read SEC document
June 01, 2021 Filed Jun 3, 2021 21:10 UTC Exercise / conversionStock Option · Derivative 1,000 $0.00 Strike: $34.00 $0.00
Disclosure

SEC source: 0001438133-21-000088 · wf-form4_162275456876148.xml · derivative · entry 3

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,500

Underlying: Common Stock · 1,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option shall vest in 36 equal monthly installments from January 2, 2019.

F5 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
June 01, 2021 Filed Jun 3, 2021 21:10 UTC SaleCommon Stock 1,000 $85.11 $85,114.50
Disclosure

SEC source: 0001438133-21-000088 · wf-form4_162275456876148.xml · nonDerivative · entry 2

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,892

F2 · kind: The shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 3, 2020.

F3 · price: The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $85 to $85.52. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.

Read SEC document
June 01, 2021 Filed Jun 3, 2021 21:10 UTC Exercise / conversionCommon Stock 1,000 $34.00 $34,000.00
Disclosure

SEC source: 0001438133-21-000088 · wf-form4_162275456876148.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,892

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
May 28, 2021 Filed Jun 1, 2021 23:27 UTC
BERGER DAVID BEVP, Chief Business/Compliance
Exercise / conversionStock Option · Derivative 1,854 $0.00 Strike: $9.00 $0.00
Disclosure

SEC source: 0001438133-21-000084 · wf-form4_162259001021917.xml · derivative · entry 8

BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,854 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The options vested as to twenty-five percent (25%) of the underlying shares on 5/17/2018, and the remaining shares vested in thirty-six (36) equal monthly installments thereafter.

F9 · derivative.expiration_date: The expiration date for these options is 10 years from the date of grant.

Read SEC document
May 28, 2021 Filed Jun 1, 2021 23:27 UTC
BERGER DAVID BEVP, Chief Business/Compliance
SaleCommon Stock 1,765 $86.49 $152,654.85
Disclosure

SEC source: 0001438133-21-000084 · wf-form4_162259001021917.xml · nonDerivative · entry 5

BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,042

Read SEC document
May 28, 2021 Filed Jun 1, 2021 23:27 UTC
BERGER DAVID BEVP, Chief Business/Compliance
SaleCommon Stock 1,854 $86.45 $160,278.30
Disclosure

SEC source: 0001438133-21-000084 · wf-form4_162259001021917.xml · nonDerivative · entry 4

BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,807

Read SEC document
May 28, 2021 Filed Jun 1, 2021 23:27 UTC
BERGER DAVID BEVP, Chief Business/Compliance
Exercise / conversionCommon Stock 1,854 $9.00 $16,686.00
Disclosure

SEC source: 0001438133-21-000084 · wf-form4_162259001021917.xml · nonDerivative · entry 3

BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,661

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents shares of common stock received upon exercise of a stock option award.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:14 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 1,626 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000073 · wf-form4_162258926050046.xml · derivative · entry 4

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,878

Underlying: Common Stock · 1,626 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company.

F5 · kind: This RSU award was granted on May 27, 2020. 25% of the RSU vested on May 27, 2021 and the remaining units shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F6 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F6 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:14 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Tax withholdingCommon Stock 563 $85.65 $48,220.95
Disclosure

SEC source: 0001438133-21-000073 · wf-form4_162258926050046.xml · nonDerivative · entry 2

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,879

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:14 UTC
Vosseller LeighEVP & CHIEF FINANCIAL OFFICER
Exercise / conversionCommon Stock 1,626 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000073 · wf-form4_162258926050046.xml · nonDerivative · entry 1

Vosseller Leigh · CIK 0001726322 · EVP & CHIEF FINANCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,442

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:28 UTC Exercise / conversionRestricted Stock Unit · Derivative 1,892 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000086 · wf-form4_162259011764091.xml · derivative · entry 4

ROEDER DOUGLAS A · CIK 0001270735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,892 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F4 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company.

F5 · kind: This RSU award was granted on May 27, 2020. 100% of the RSU vested on May 27, 2021.

F6 · derivative.exercise_date: RSU vest as to one-hundred percent (100%) of the total number of shares subject to the RSU on 5/27/2021.

F6 · derivative.expiration_date: RSU vest as to one-hundred percent (100%) of the total number of shares subject to the RSU on 5/27/2021.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:28 UTC Exercise / conversionCommon Stock 1,892 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000086 · wf-form4_162259011764091.xml · nonDerivative · entry 1

ROEDER DOUGLAS A · CIK 0001270735 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,892

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:27 UTC
BERGER DAVID BEVP, Chief Business/Compliance
Exercise / conversionRestricted Stock Unit · Derivative 1,626 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000084 · wf-form4_162259001021917.xml · derivative · entry 7

BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,878

Underlying: Common Stock · 1,626 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company.

F6 · kind: This RSU award was granted on May 27, 2020. 25% of the RSU vested on May 27, 2021 and the remaining units shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F7 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F7 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:27 UTC
BERGER DAVID BEVP, Chief Business/Compliance
Tax withholdingCommon Stock 681 $85.65 $58,327.65
Disclosure

SEC source: 0001438133-21-000084 · wf-form4_162259001021917.xml · nonDerivative · entry 2

BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,807

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:27 UTC
BERGER DAVID BEVP, Chief Business/Compliance
Exercise / conversionCommon Stock 1,626 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000084 · wf-form4_162259001021917.xml · nonDerivative · entry 1

BERGER DAVID B · CIK 0001422126 · EVP, Chief Business/Compliance

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,488

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:19 UTC Exercise / conversionRestricted Stock Unit · Derivative 1,892 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000082 · wf-form4_162258956819285.xml · derivative · entry 4

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,892 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F4 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company.

F5 · kind: This RSU award was granted on May 27, 2020. 100% of the RSU vested on May 27, 2021.

F6 · derivative.exercise_date: RSU vest as to one-hundred percent (100%) of the total number of shares subject to the RSU on 5/27/2021.

F6 · derivative.expiration_date: RSU vest as to one-hundred percent (100%) of the total number of shares subject to the RSU on 5/27/2021.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:19 UTC Exercise / conversionCommon Stock 1,892 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000082 · wf-form4_162258956819285.xml · nonDerivative · entry 1

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,892

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:19 UTC Exercise / conversionRestricted Stock Unit · Derivative 1,892 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000081 · wf-form4_162258954202618.xml · derivative · entry 3

BLICKENSTAFF KIM D · CIK 0001238913 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,892 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F3 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company.

F4 · kind: This RSU award was granted on May 27, 2020. 100% of the RSU vested on May 27, 2021.

F5 · derivative.exercise_date: RSU vest as to one-hundred percent (100%) of the total number of shares subject to the RSU on 5/27/2021.

F5 · derivative.expiration_date: RSU vest as to one-hundred percent (100%) of the total number of shares subject to the RSU on 5/27/2021.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:19 UTC Exercise / conversionCommon Stock 1,892 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000081 · wf-form4_162258954202618.xml · nonDerivative · entry 1

BLICKENSTAFF KIM D · CIK 0001238913 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,892

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:17 UTC Exercise / conversionRestricted Stock Unit · Derivative 1,892 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000078 · wf-form4_162258944780428.xml · derivative · entry 2

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,892 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F2 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company.

F3 · kind: This RSU award was granted on May 27, 2020. 100% of the RSU vested on May 27, 2021.

F4 · derivative.exercise_date: RSU vest as to one-hundred percent (100%) of the total number of shares subject to the RSU on 5/27/2021.

F4 · derivative.expiration_date: RSU vest as to one-hundred percent (100%) of the total number of shares subject to the RSU on 5/27/2021.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:17 UTC Exercise / conversionCommon Stock 1,892 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000078 · wf-form4_162258944780428.xml · nonDerivative · entry 1

ROBERTSON REBECCA B · CIK 0001201585 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,892

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:17 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionRestricted Stock Unit · Derivative 1,626 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000077 · wf-form4_162258942269128.xml · derivative · entry 3

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,878

Underlying: Common Stock · 1,626 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company.

F4 · kind: This RSU award was granted on May 27, 2020. 25% of the RSU vested on May 27, 2021 and the remaining units shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:17 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Tax withholdingCommon Stock 528 $85.65 $45,223.20
Disclosure

SEC source: 0001438133-21-000077 · wf-form4_162258942269128.xml · nonDerivative · entry 2

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,059

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:17 UTC
HANSEN BRIAN BEVP & CHIEF COMMERCIAL OFFICER
Exercise / conversionCommon Stock 1,626 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000077 · wf-form4_162258942269128.xml · nonDerivative · entry 1

HANSEN BRIAN B · CIK 0001542377 · EVP & CHIEF COMMERCIAL OFFICER

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,587

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:15 UTC
Allen DickDirector
Exercise / conversionRestricted Stock Unit · Derivative 1,892 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000074 · wf-form4_162258930001208.xml · derivative · entry 6

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,892 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F6 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the Company.

F7 · kind: This RSU award was granted on May 27, 2020. 100% of the RSU vested on May 27, 2021.

F8 · derivative.exercise_date: RSU vest as to one-hundred percent (100%) of the total number of shares subject to the RSU on 5/27/2021.

F8 · derivative.expiration_date: RSU vest as to one-hundred percent (100%) of the total number of shares subject to the RSU on 5/27/2021.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:15 UTC
Allen DickDirector
Exercise / conversionCommon Stock 1,892 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000074 · wf-form4_162258930001208.xml · nonDerivative · entry 1

Allen Dick · CIK 0001582779 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,892

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:12 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionRestricted Stock Unit · Derivative 1,626 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000070 · wf-form4_162258913214294.xml · derivative · entry 3

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,878

Underlying: Common Stock · 1,626 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Tandem common stock.

F4 · kind: This RSU award was granted on May 27, 2020. 25% of the RSU vested on May 27, 2021 and the remaining units shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:12 UTC
Morrison SusanEVP & Chief Admin. Officer
Tax withholdingCommon Stock 466 $85.65 $39,912.90
Disclosure

SEC source: 0001438133-21-000070 · wf-form4_162258913214294.xml · nonDerivative · entry 2

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,712

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 23:12 UTC
Morrison SusanEVP & Chief Admin. Officer
Exercise / conversionCommon Stock 1,626 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000070 · wf-form4_162258913214294.xml · nonDerivative · entry 1

Morrison Susan · CIK 0001582970 · EVP & Chief Admin. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,178

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 22:56 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionRestricted Stock Unit · Derivative 3,279 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000068 · wf-form4_162258815739067.xml · derivative · entry 3

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,837

Underlying: Common Stock · 3,279 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan).

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of the Company.

F4 · kind: This RSU award was granted on May 27, 2020. 25% of the RSU vested on May 27, 2021 and the remaining units shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.

F5 · derivative.exercise_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

F5 · derivative.expiration_date: RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/27/2021, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 22:56 UTC
Sheridan John FDirector · PRESIDENT & CEO
Tax withholdingCommon Stock 1,134 $85.65 $97,127.10
Disclosure

SEC source: 0001438133-21-000068 · wf-form4_162258815739067.xml · nonDerivative · entry 2

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,197

F1 · kind: Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.

Read SEC document
May 27, 2021 Filed Jun 1, 2021 22:56 UTC
Sheridan John FDirector · PRESIDENT & CEO
Exercise / conversionCommon Stock 3,279 $0.00 $0.00
Disclosure

SEC source: 0001438133-21-000068 · wf-form4_162258815739067.xml · nonDerivative · entry 1

Sheridan John F · CIK 0001365369 · Director · PRESIDENT & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,331

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 19, 2021 Filed May 21, 2021 01:33 UTC Exercise / conversionWarrant · Derivative 135 $73.73 Strike: $73.73 $9,953.01
Disclosure

SEC source: 0001438133-21-000050 · wf-form4_162156078319824.xml · derivative · entry 7

TWOMEY CHRISTOPHER J · CIK 0001238935 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

Underlying: Common Stock · 135 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.expiration_date: The expiration date for this warrant is August 31, 2021.

F3 · ownership.nature: The securities are directly owed by Twomey Family Investments, LLC. The Reporting Person is co-manager of Twomey Family Investments, LLC and shares voting and investment power over the securities held by Twomey Family Investments, LLC and may be deemed to have indirect beneficial ownership of such shares. The Reporting Person disclaims beneficial ownership of such securities held by Twomey Family Investments, LLC, except to the extent of his proportionate pecuniary interest therein.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.